Efficacy
Tolerability
Dosing
Summary
Aerius pack
Efficacy

Aerius has the power to relieve 12 of the tough allergy symptoms.1,2

Throat icon

Throat

  • Itching of palate
  • Allergic cough
Skin icon

Skin

  • Skin itching
  • Size and number of hives
Eyes icon

Eyes

  • Eye itching
  • Eye tearing
  • Redness
Nose icon

Nose

  • Sneezing
  • Nasal discharge & itching
  • Nasal congestion
1. Aerius™ Tablet PIL
2. Aerius™ Syrup PIL

Aerius provides all day relief around the clock.1,2

AERIUS™ 1–3 t1/2 = 27 h
Bilastine3
t1/2 = 14.5 h
Cetirizine3
t1/2 = 10 h
Levocetirizine3
t1/2 = 7.9 h
Fexofenadine3
t1/2 = 11–15 h
Bilastine3
t1/2 = 14.5 h
Cetirizine3
t1/2 = 10 h
Levocetirizine3
t1/2 = 7.9 h
Fexofenadine3
t1/2 = 11–15 h
Aerius™ Tablet PIL.
Aerius™ Syrup PIL.
Kawauchi H, Yanai K, Wang DY, Itahashi K, Okubo K. Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. International Journal of Molecular Sciences. 2019;20(1):213.

The mean reduction of AM/PM reflective T5SS was significantly greater with Aerius than with placebo over 15 days.1

The efficacy of Aerius in intermittent allergic rhinitis1

T5SS: Total 5-symptom score.
1. Bousquet J, Bachert C, Canonica GW, et al. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy. 2009;64(10):151623.

The mean reduction of AM/PM reflective T5SS1

chart 1

The mean reduction in AM/PM reflective T5SS was significantly greater with Aerius than placebo over days 1–29.1

The efficacy of Aerius in persistent allergic rhinitis1

T5SS: Total 5-symptom score.
1. Bousquet J, Bachert C, Canonica GW, et al. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy. 2009;64(10):151623.

The mean reduction of AM/PM reflective T5SS1

chart 2

The mean reduction of AM/PM reflective T5SS was significantly greater with Aerius than with placebo over 15 days.1

Efficacy of Aerius in intermittent allergic rhinitis1

T5SS: Total 5-symptom score.
1. Bousquet J, Bachert C, Canonica GW, et al. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy. 2009;64(10):151623.

The mean reduction of AM/PM reflective T5SS1

chart 2
arrow-down

Aerius significantly reduced sleep problems in AR patients by 32% at Day 14.1

Treatment with Aerius tablets improved sleep quality in AR patients1

AR: Allergic rhinitis
1. Aerius™ Tablet PIL.
2. Pradalier A, Neukirch C, Dreyfus I, Devillier P. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis. Allergy. 2007;62(11):133134.

Aerius significantly decreased subjects’ overall condition (combined score for itching and number of hives) by 48% at Day 14.1

Treatment with Aerius resulted in moderate, marked, or complete relief of symptoms in 76.2% of subjects.1

1. Kim H, Lynde C. Impact of Desloratadine on Symptoms and Quality of Life in Subjects with Chronic Idiopathic Urticaria: A Multicenter, Practicebased Study. Archives of Drug Information. 2008;1(2):639

Overall condition and symptom scores Impact of Aerius on symptoms in CIU patients

chart 2
Tolerability

The tolerability of Aerius is rated as “good” or “excellent” by the majority of clinicians and patients.1

Treatment with Aerius tablets improved sleep quality in AR patients1

1. Bachert C, Maurer M. Safety and eicacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria. Clinical Drug Investigation. 2010;30(2):10922.
chart 2
Dosing

ONCE

Daily

twice-daily-2x

One

Tablet

Adults and adolescents
12 years of age and older

1. Aerius™ Tablet PIL.
Summary
aerius-tablets
  • In intermittent allergic rhinitis, Aerius™ shows significantly greater reduction in the mean of AM/PM reflective T5SS vs. placebo.1
  • In persistent allergic rhinitis, Aerius™ shows significantly greater reduction in the mean AM/PM reflective T5SS vs. placebo.2
  • Aerius™ significantly improved sleep quality in AR patients.3
  • Aerius™ has a favorable tolerability profile.4
T5SS=total 5 symptom score, AR=allergic rhinitis
1. Bousquet J, Bachert C, Canonica GW, et al. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy. 2009;64(10):151623.
2. Bousquet J, Bachert C, Canonica GW, et al. Efficacy of desloratadine in persistent allergic rhinitis–a GA2LEN study. International Archives of Allergy and Immunology. 2010;153(4):395402.
3. Aerius™ Tablet PIL.
4. Bachert C, Maurer M. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria. Clinical Drug Investigation. 2010;30(2):10922.